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Abstract
Rheumatoid arthritis (RA) is a chronic inflammatory and debilitating joint 
disorder that causes severe impairment and reduces the quality of life. The avail-
able synthetic medicines used as standard therapy for RA have numerous side 
effects that can compromise their therapeutic outcomes. Thus, the demand for 
alternative and complementary medicines is increasing. A search of English articles 
in PubMed, Scopus, Google Scholar, and Web of Science databases was carried 
out on probable mechanisms of action of herbs with the antirheumatic property. 
Herbal medicines stated in folk medicine face acceptance concerns by the medical 
community because of the lack of scientific documents regarding their physio-
pharmacological mechanisms. This chapter aims to review the possible antirheu-
matic effects of various herbs, including Rosmarinus officinalis L., Curcuma longa, 
and Crocus sativus, their related mechanisms, and preclinical applications, in order 
to recall the therapeutic properties of herbal medicine. However, more clinical 
trials are required to confirm the safety and efficacy of these antirheumatic herbal 
medicines.
Keywords: rheumatoid arthritis, antirheumatic, herbal medicine, folk medicine, 
complementary drugs, physio-pharmacological effects
1. Introduction
Rheumatoid arthritis (RA) is a chronic systemic autoimmune disorder that can 
strike men and women at any age [1]. About 1% of the world’s population has been 
affected by RA, which has resulted in progressive articular damage, permanent 
impairment, and even reduced life expectancy [2]. Genetic and environmental 
factors have important roles in the aetiopathogenesis of RA [3]. The pathophysiol-
ogy of RA is complex and mainly focuses on autoimmune response and inflam-
mation [4]. The reactive oxygen species (ROS) damage proteins such as collagen 
and denature immunoglobulins that both might become autoantigens in RA [5]. 
Autoantibodies against immunoglobulin G (IgG) (also called rheumatoid factors 
(RFs)) and autoantibodies against citrullinated peptides (ACPAs) are two types of 
autoantibodies that can cause complement activation in RA patients [6, 7]. It was 
suggested that increased circulating ACPAs can promote bone loss by activating 
macrophages, producing B cells, organizing immune complexes or binding mem-
brane citrullinated vimentin [8–11] which consequently ease the shift from autoim-
munity to inflammation. Inflammation of the synovial membrane in RA is made up 
of both innate and adaptive immune cells [12]. The majority of immune responses 
are regulated by cytokines and chemokines including interleukin-6 (IL-6) and 
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tumor necrosis factor (TNF) which can induct or intensify the inflammatory 
response of the synovial compartment [13].
Disease-modifying anti-rheumatic drugs (DMARDs), glucocorticoids, and 
nonsteroidal anti-inflammatory drugs (NSAIDs) are currently available drugs for 
RA [14]. Antirheumatic medications that are currently available for RA treatment 
target the inflammation and tissue swelling resulting from the disease. However, 
the majority of patients still experience extreme pain and physical impairment. 
These drugs are ineffective in preventing cartilage degradation and joint damage 
[15]. It was also reported that taking two or more biologic DMARDs at the same 
time, or a biologic DMARD with a nonbiologic DMARD, increases the risk of severe 
infections or cancer [16]. Other investigations have also illustrated the cardiovas-
cular [17] and ocular [18] adverse effects of antirheumatic drugs. Therefore, the 
development of safe, fast-acting antirheumatic medicines is required.
Complementary and alternative medicine methods are now thought to provide 
adjuvant therapies to improve the chances of full remission of RA [19, 20]. Several 
herbal medicines have displayed pre-clinical and clinical antirheumatic properties 
including Curcuma longa L., Rosmarinus officinalis L., and Crocus sativus through 
their antioxidant, anti-inflammatory, anti-proliferative, and antinociceptive 
properties (Figure 1).
Figure 1. 
Some herbal medicines with antirheumatic property.
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Thus, searching for herbal medicines with antirheumatic properties could be 
an advantageous method to find effective antirheumatic medicines with fewer side 
effects. The detailed information about medicinal herbs and their physio-pharma-
cological mechanisms of action is summarized in this chapter.
2. Methods
The present chapter mainly emphasizes the published original articles implicat-
ing the therapeutic and beneficial effects of herbs on rheumatoid arthritis. The 
data (Google Scholar, PubMed, and Scopus) search has been carried out by search-
ing related keywords, including “rheumatoid arthritis”, “rosemary”, “Rosmarinus 
officinalis L.”, “turmeric”, “Curcuma longa L.”, “Crocus sativus L.”, “saffron”, “Zingiber 
officinale”, “ginger”, “Nigella sativa”, “black seed”, “black cumin”, “Camellia sinensis”, 
and “green tea”. No time limitation was considered.
2.1 Herbal antirheumatic medicines
In folk medicine, numerous plants have been used because of their antirheu-
matic properties. Researchers are currently focusing on evaluating and character-
ization of different plants and their components to treat RA. The aim of this section 
of the chapter is to review the mechanism of action of a number of medicinal plants 
that have antirheumatic properties.
2.2 Rosmarinus officinalis L. (rosemary)
A former study indicated that administration of water-soluble compounds of 
rosemary reduced oxidative stress (by enhancing the glutathione (GSH) level and the 
GSH/glutathione disulfide (GSSG) ratio) and inflammation (paw edema, number of 
leukocytes in the femorotibial joint cavities, secondary lesions score, adrenal glands, 
inguinal lymph nodes, and popliteus lymph nodes weights) in rats with adjuvant-
induced arthritis [21]. Carnosic acid, a major phenolic compound isolated from 
rosemary (5 mg/kg, 2 weeks, i.p.), administration to collagen-induced arthritis rats 
inhibited inflammation response and joint destruction by decreasing the amounts of 
TNF-ɑ, IL-1β, IL-6, IL-8, IL-17, matrix metalloproteinase-3 (MMP-3), and receptor 
activator of nuclear factor kappa-Β ligand (RANKL) [22] (Table 1). Moreover, it was 
observed that a methyl ester derivative of rosmarinic acid, a constituent of rosemary 
(50 mg/kg/day, 15 days, i.p.), has a potent anti-arthritic property in collagen-induced 
arthritis mice via its anti-inflammatory and immunosuppressive effects [34].
Another study has reported that rosmarinic acid triggers apoptosis via mito-
chondrial pathway in activated T cells taken from rheumatoid arthritis patients [35].
2.3 Curcuma longa L. (turmeric)
A clinical trial was carried out on 45 patients with RA to investigate the 
antirheumatic effect of curcumin at the dose of 500 mg for 8 weeks. Curcumin 
improved disease activity and the American college of rheumatology scores [36]. 
Another clinical trial reported that curcumin in a turmeric matrix (250 mg, twice 
daily, 90 days) was an advantageous agent in managing RA by its analgesic and 
anti-inflammatory properties. Curcumin improved erythrocyte sedimentation rate, 
C-reactive protein, visual analog scale, rheumatoid factor, and American College 
of Rheumatology responses in comparison with the control group [37]. It was also 
seen that administration of CuroWhite™, a novel hydrogenated curcuminoid 
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formulation, at the dose of 250 mg and 500 mg for 3 months ameliorated RA by its 
anti-inflammatory and antinociceptive effects which was confirmed by improv-
ing erythrocyte sedimentation rate, rheumatoid factor, visual analog scale, and 
C-reactive protein [25]. A recent clinical study reported that administration of 
curcumin (200–1000 mg) to patients with RA decreased pain, fatigue, stiffness, 
and swelling [26]. The results of a clinical trial indicated that the prescription of 
BioSOLVE Curcumin™ (250 mg, 12 weeks) to patients with RA improved the 
American college of rheumatology-20, Western Ontario and McMaster universities 
osteoarthritis index and visual analogue scale score [28].
A turmeric extract devoid of essential oils was given to Wistar female rats in 
an animal model of streptococcal cell wall-induced RA. Injections of an extract 
containing 4 mg/kg/day total curcuminoids intraperitoneally for four days prior 
to arthritis induction significantly reduced joint inflammation in both the acute 
(75%) and chronic (68%) phases [38]. A previous investigation stated that the 
administration of C. longa extract (30, 60, and 110 mg/ml/kg, 4 weeks) prevented 
degenerative alterations in the joints and bones of collagen-induced arthritic rats 
[30]. It was also observed that turmeric (200 mg/kg, 28 days, p.o.) significantly 
reduced the incidence and severity of arthritis by increasing the production of anti-
inflammatory agents and decreasing the amount of pro-inflammatory cytokines, 
as well as stimulating the anti-oxidant defense system [31]. Furthermore, turmeric 
Herbal medicine Antirheumatic Mechanism(s) Reference
Rosmarinus officinalis L. ↑ GSH level [21]
↑ GSH/GSSG ratio
↓ Number of leukocytes in the femorotibial joint cavities
↓ TNF-α, IL-1β, IL-6, IL-8, IL-17, MMP-3, RANKL [22]
↑ Apoptosis [23]
Curcuma longa L. ↓ Erythrocyte sedimentation rate [24]
↓ C-reactive protein [25, 26]
↓ PGE2, COX-2, TNF-α, and IL-1
↓ Bcl-2
↑ Bax, caspase 3, 9 [27]
↓ MAPK/RANK/c-Fos/NFATC1





↑ Catalase and glutathione peroxidase [30–33]
↓ IL-1β, IL-6, IL-17, IL-8, NF-κB
↑ SOD, GR
Bax: BCL2-associated X; Bcl-2: B-cell lymphoma-2; COX: cyclooxygenase; GSH: glutathione; GR: glutathione 
reductase; GSSG: glutathione disulfide; interferon gamma (IFNγ), IL: interleukin; MAPK: mitogen-activated 
protein kinase; MDA: malondialdehyde, MMP: matrix metalloproteinase; NFATC1: Nuclear Factor of Activated 
T Cells 1; NF-κB: nuclear factor kappa B; PGE2: Prostaglandin E2; RANKL: receptor activator of nuclear factor 
kappa-B ligand, SOD: superoxide dismutase; TNF: tumor necrosis factor.
Table 1. 
Antirheumatic mechanisms of action of R. officinalis L., Curcuma longa L., and Crocus sativus L.
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(containing 60% v/v alcohol) mother tinctures decreased hind paw swelling in 
carrageenan-treated rats [32].
The findings of an in vitro study indicated that curcumin inhibited the produc-
tion of prostaglandin E2 (PGE2) and induced apoptosis in synovial fibroblasts of 
patients with RA by reducing the level of B-cell lymphoma-2 (Bcl-2), an anti-apop-
totic protein, upregulated the amount of BCL2-associated X (Bax), a pro-apoptotic 
protein, and activated caspase-3 and caspase-9. Besides, curcumin attenuated the 
cyclooxygenase (COX)-2 mRNA expression level [23]. The findings of another 
research confirmed that curcumin could inhibit the osteoclastogenic potential 
of peripheral blood mononuclear cells from patients with RA by suppressing the 
mitogen-activated protein kinase/Receptor activator of nuclear factor-kappa B/c-
Fos/Nuclear Factor of Activated T Cells 1 (MAPK/RANK/c-Fos/NFATC1) signaling 
pathways, and it was suggested that curcumin might be an effective therapeutic 
agent for treating bone deterioration in inflammatory diseases including RA [24]. 
In another investigation, human fibroblast-like synoviocytes isolated from RA 
patients were treated with the IC50 of the curcumin. Curcumin downregulated the 
expression of the inflammatory response gene. Moreover, the authors suggested 
that prescribing curcumin along with the usual therapies could increase the quality 
of life in RA patients [39].
The data of an in silico study disclosed that herbal compounds present in tur-
meric have strong inhibitory properties against the pro-inflammatory cytokines 
including TNF-α and IL-1. It was also proposed that turmeric has therapeutic 
potentials to be used for treating RA [40].
2.4 Crocus sativus L. (saffron)
A clinical trial was carried on 66 women with RA to assess the effect of saf-
fron (100 mg/day, 12 weeks) supplementation on their metabolic profiles and 
clinical outcomes. According to the obtained data, saffron considerably reduced 
the number of swollen and tender joints, pain intensity, and disease activity score 
compared to baseline values. Moreover, erythrocyte sedimentation rate was signifi-
cantly improved and high-sensitivity C-reactive protein, TNF-α, interferon-gamma 
(IFNγ), and MDA levels reduced [41].
In an in vivo study, the efficiency of saffron was assessed on adjuvant-induced 
arthritic mice. As the results showed the daily administration of the saffron extract 
(25, 50, and 100 mg/kg, 47 days, p.o.) decreased the amount of lipid peroxides level 
and increased the activity of catalase and glutathione peroxidase [42]. The effect of 
saffron ethanolic extract (25–600 mg, 12 days, every other day, i.p.) was studied in 
an adjuvant-induced arthritis rat model. The results revealed that saffron ethanolic 
extract chiefly at the higher concentrations meaningfully attenuated tibiotarsal 
joint and paw diameters in comparison to the control group. It has also been sug-
gested that saffron ethanolic extract could be potentially used as an anti-arthritic 
agent in managing inflammation in RA [43]. An investigation examined the effect 
of saffron extract (50, 100 mg/kg, 47 days, p.o.) on adjuvant-induced arthritis in 
mice. It was observed that saffron could remarkably reduce TNF-α and IL-1β levels. 
It also increased superoxide dismutase (SOD) and glutathione reductase (GR) 
activity [44]. Another in vivo study was planned to determine the effect of crocin, a 
carotenoid constituent of saffron, on the rat RA model. It was seen that intradermal 
prescription of crocin (6.25, 12.5, and 25 mg/kg, 28 days) pointedly alleviated the 
paw swelling, decreased arthritis score, the thymus index, the inducible nitric oxide 
synthase (iNOS) production, and the serum amount of TNF-α, IL-1β, and IL-6 [27]. 
Moreover, it was reported that crocin (40 mg/kg, 36 days, p.o.) shows therapeutic 
potential for RA, by mitigating the symptoms and preventing the expression of 
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pro-inflammatory factors including TNF-α, IL-17, IL-6, and IL-8 in ankle tissues and 
serum of collagen-induced arthritic rats [29]. It was also illustrated that crocin treat-
ment (50 mg/kg, a week, i.p.) significantly decreased the amounts of TNF-α, IL-1β, 
and IL-6 in collagen-induced arthritic mice through blocking nuclear factor kappa B 
(NF-κB) signal activation by its interaction with IκB kinase (IKK) [33] (Table 1).
2.5 Zingiber officinale (ginger)
A former clinical trial was carried out on 6 patients with RA who took ginger 
powder (0.5–1 g/day, 3 months). It was found that all six patients reported pain 
relief, improved joint mobility, decreased swelling, and morning stiffness after 
three months of continuous ginger intake. There were no side effects recorded 
by any of the participants, and they all seemed to be happier and more engaged 
in their daily lives [45]. Another study investigated the effect of ginger on 56 
RA patients. The findings revealed that after taking ginger (50 g/day raw/fresh, 
3 months-2.5 years) more than three-quarters of participants reported pain and 
swelling relief to varying degrees. Also, all the subjects with muscular discomfort 
experienced pain relief. The authors suggested that at least one of the mechanisms 
by which ginger exerts its beneficial effects is thought to be linked to inhibition of 
prostaglandin and leukotriene biosynthesis, implying that it acts as a dual eico-
sanoid biosynthesis inhibitor [46]. The results of another study demonstrated that 
ginger powder (1500 mg, 12 weeks) administration ameliorated RA by reducing 
disease manifestations through controlling immunity factors, for instance enhanc-
ing the gene expression of forkhead box P3 (FoxP3), as well as attenuating RAR-
related orphan receptor gamma (RORγt), and T-bet genes expression [47].
Prescription of Z. officinale (> 50 mg/kg/day, 26 days, i.p.) amended the disease 
incidence, clinical scores, cartilage destruction, swelling and temperature of the 
joint in rat collagen-induced arthritis. It also reduced serum levels of IL-1β, IL-2, 
IL-6, TNF-α, and anti-collagen type II (CII) antibodies [48]. The anti-inflammatory 
property of the essential oil of ginger was assessed in an experimental model of 
RA in female rats and it was observed that ginger essential oil (28 mg/kg, 28 days, 
i.p.) ameliorated chronic joint inflammation. These findings indicate that the 
anti-inflammatory properties of ginger are due to a combination of secondary 
metabolites, pungent-tasting gingerols, and aromatic essential oils, rather than only 
the phenolic compounds that have been studied previously [49]. A recent document 
explained that oral administration of zingerone, an active constituent of ginger 
(25 mg/kg, 3 weeks), to adjuvant-induced RA rats considerably decreased the 
amounts of NF-κB, transforming growth factor-beta (TGF-β), TNF-α, IL-1β, IL-6, 
and high-sensitivity C-reactive protein (hs-CRP), and significantly enhanced IL-10 
levels. Moreover, zingerone restored the amounts of antioxidant enzymes [50]. 
Cedrol, a ginger active component, has been shown to improves RA by decreasing 
inflammation and preventing Janus kinase 3 (JAK3) phosphorylation [51].
Ginger extract was found to be an advantageous anti-inflammatory agent in an 
in vitro model on cultured fibroblast-like synoviocytes from RA patients by inhibit-
ing the production of cytokines [52].
2.6 Nigella sativa (black seed, black cumin)
The efficiency of N. sativa oil was studied in the management of RA. The subjects 
of the treatment group took N. sativa oil capsules (500 mg, twice a day, 1 month). 
The results disclosed that the disease activity score, the number of swollen joints, 
and the duration of morning stiffness remarkably reduced compared with the 
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placebo group [53]. Assessing the effects of N. sativa oil extract (500 mg, twice a day, 
8 weeks) on oxidative stress status and inflammatory cytokine response in patients 
with RA indicated that the serum amount of IL-10 augmented in the N. sativa group, 
besides serum malondialdehyde (MDA) and nitric oxide (NO) levels decreased 
compared with the baseline [54]. Another clinical trial reported that administration 
of N. sativa oil (1 g/day, in two divided doses, 2 months) to 43 female patients with 
mild to moderate RA led to a significant decrease of the serum hs-CRP amount and 
the number of swollen joints. A moderately similar T helper cells (CD4+ T cell) per-
centage was detected in the N. sativa oil and placebo groups. N. sativa also decreased 
CD8+, and amplified CD4+CD25+ T cell percentage and the CD4+/CD8+ ratio in 
comparison with the baseline and placebo group [55] (Table 2).
Evaluating the effects of thymoquinone, the volatile oil of black cumin (2.5, 
5 mg/kg, 14 days, p.o.), on RA model in rats disclosed that signs of inflammation on 






↓ Prostaglandin and leukotriene [47]
↑ FoxP3
↓ RORγt, and T-bet [48, 50]









↑ CD4+CD25+ T cell, CD4+/CD8+ ratio [56]
↓ TNF-α, IL-iβ [57]
↓ PGE2, TNF-a, IL-ib, IL-6, IFN-c, TNF-α-induced phospho-p38 and 
phospho-JNK
[58]
↓ MPO, elastase activity, lipid peroxidation, articular nitrite content
↑ GSH and SOD
↓ NFκB, TLR2, and TLR4 [59]
Camellia sinensis ↓ Oxidative stress [60]
↓ Blood leukocytosis and erythrocyte sedimentation rate [61]
↓ Free radical levels [62]
↓ IL-iβ, IL-6, IL-8, and COX-2 [63]
CD4+ T cell: T helper cells, CII: collagen type II, COX: cyclooxygenase; FoxP3: forkhead box P3; GSH: glutathione; 
hs-CRP: high-sensitivity C-reactive protein; IFN-c: Interferon-c; IL: interleukinJAK3: Janus kinase 3; JNK: c-Jun 
N-terminal kinases, MDA: malondialdehyde, MPO: myeloperoxidase; NF-κB: nuclear factor kappa B; NO: nitric 
oxide, PGE2: Prostaglandin E2; RORγt: RAR-related orphan receptor gamma; SOD: superoxide dismutase; TGF-β: 
transforming growth factor-beta, TLR: toll like receptor; TNF: tumor necrosis factor.
Table 2. 
Antirheumatic mechanisms of action of Zingiber officinale, Nigella sativa, and Camellia sinensis.
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[56]. Thymoquinone (5 mg/kg, 21 days, p.o.) treatment in the collagen-induced 
arthritis in Wistar rats could considerably reduce the amounts of pro-inflammatory 
mediators including PGE2, TNF-a, IL-1b, IL-6, Interferon-c (IFN-c), and increased 
IL-10 level. Thymoquinone also decreased arthritis scoring and improved bone 
histology [57]. Administration of the aqueous methanolic extract of black seed 
(400, 500 mg/kg, 20 days, p.o.) to arthritic rats decreased myeloperoxidase (MPO), 
elastase activity, lipid peroxidation, articular nitrite content, and increased GSH 
and SOD amounts [64]. In another rat model of RA, N. sativa oil (0.91, 1.82 mL/
kg (798, 1596 mg/kg, respectively), 25 days, p.o.) was administered to animals. N. 
sativa oil exhibited anti-inflammatory, anti-nociceptive, and anti-arthritic proper-
ties that were significant in comparison with the untreated arthritic rats [59]. The 
results of an in vivo study demonstrated that thymoquinone (10 mg/kg, 28 days, 
i.p.) administration arthritic rats attenuated the macroscopic arthritic score, pannus 
formation, synovial inflammation, bone erosion and CRP amount. Moreover, 
mRNA levels of IL-1, TNF-α, NFκB, TLR2, and TLR4 were reduced [60].
An in vitro study explained that thymoquinone inhibited TNF-α-induced 
phospho-p38 and phospho-c-Jun N-terminal kinases (JNK) expression in RA 
synovial fibroblast [57].
2.7 Camellia sinensis (green tea)
Evaluating the therapeutic effects of green tea (0.5, 1.0 g/kg, 24 days, p.o.) on 
articular/extra-articular difficulties in rat adjuvant-induced arthritis revealed that 
the arthritis severity and complications besides oxidative stress ratio in synovial 
fluid were significantly reduced [61]. In another in vivo study, adjuvant-induced 
arthritic rats received green tea aqueous extracts (0.5 and 1.0 g/kg, p.o.) for 28 or 
14 consecutive days starting from day 0 or 14 of arthritis induction, respectively). 
It was observed that the high dose of green tea amended synovial joint inflamma-
tion, reduced blood leukocytosis and erythrocyte sedimentation rate, and changes 
in weight/cellularity of lymphoid organs. It also decreased the systemic production 
of pro-inflammatory cytokines and the expression of chemokine receptor-5 in 
synovial tissues [65]. Aqua-alcoholic extract of green tea (50, 100, 200, 400 mg/kg, 
14 days, p.o.) was prescribed to collagen-induced arthritic rats. The findings showed 
that green tea was useful in reducing the ratio of oxidative stress by controlling 
the amounts of antioxidants, decreasing free radical levels, and restoring normal 
hematopoietic cascade [58]. The therapeutic potential of green tea was evaluated in 
an experimental model of RA in Lewis rats. The data showed that green tea reduced 
paw edema, bone erosion, and inflammatory responses in joints of treated rats. It 
also reduced telomerase activity in comparison with the control group [62].
In an in vitro study, crude aqueous C. sinensis (50, 100, 200, 400 μg/ml) infu-
sion and decoction revealed anti-arthritic properties in protein denaturation and 
membrane stability methods [66]. It was also found that catechins derived from C. 
sinensis (epigallocatechin-3-gallate, epigallocatechin, and epicatechin) inhibit the 
IL-1β signaling pathway and consequently decrease the amounts of pro-inflam-
matory mediators such as IL-6 and IL-8, as well as COX-2 in primary human RA 
synovial fibroblasts [63] (Table 2).
3. Conclusion
Herbs are spread in different geographical and ecological throughout the world. 
Since the olden days several traditional herbs have been utilized for treating plenty 
of ailments. The number of medicinal plants that have antirheumatic properties is 
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comparable to potent synthetic antidepressants. The antirheumatic effects of plants 
have been linked to their antioxidant, anti-inflammatory, analgesic properties. 
Furthermore, polyherbal formulations might be more effective due to their possible 
additive and/or synergistic effects and could be employed for ameliorating mild to 
moderate RA. As a result, it is possible to conclude that medicinal plants are at the 
center of nature and that more research is required to determine their therapeu-
tic value.
Abbreviations
ACPAs autoantibodies against citrullinated peptides
Bax BCL2-associated X
Bcl-2 B-cell lymphoma-2
CD4+ T cell T helper cells
CII collagen type II
COX cyclooxygenase
DMARDs disease-modifying anti-rheumatic drugs










iNOS inducible nitric oxide synthase
JAK3 Janus kinase 3
JNK c-Jun N-terminal kinases




NFATC1 Nuclear Factor of Activated T Cells 1





RANK Receptor activator of nuclear factor kappa B
RANKL receptor activator of nuclear factor kappa-Β ligand
RFs rheumatoid factors
RORγt RAR-related orphan receptor gamma
ROS reactive oxygen species
SOD superoxide dismutase
TGF-β transforming growth factor-beta
TLR toll like receptor
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